REGISTER FOR REGULAR UPDATES
DATE AND TIME
Thu, 4 Jun. 2020, 10:00
Thu, 4 Jun. 2020, 11:00
About this webinar
The Malaysian healthcare industry has been robust in recent years. However, the coronavirus that grips all business sectors has also disrupted the healthcare industry. Immediate interventions need to be taken. Being the top player in ASEAN and home to many multinationals and local pharma and medical device manufacturers, Malaysia surely has its own strategy to pivot during this trying time.
Join this webinar to understand the opportunities available for UK exporters. This webinar brings together subject matter experts from the government and private sector to shed light on:
- Impact of Covid-19 on policy and regulations
- Risk Management – a perspective from the local industry that represents foreign pharmaceutical products & medical devices in the country
- Opportunities for UK businesses
- What should companies do now to be ready for the future, post-COVID-19?
Ir. Sasikala Devi
Director, Policy, Code & Standard Divison, Medical Advice Authority (MDA) at the Ministry of Health, Malaysia
General Manager, Business Development Healthcare, DKSH Malaysia Sdn Bhd
Who is this webinar suitable for?
This webinar is suitable for all British companies within the healthcare industry with a vested interest in exporting to Southeast Asian markets such as Malaysia or partnering with local companies in the region.
For further information on this webinar please contact the British Malaysian Chamber of Commerce (BMCC):
Tel: +60 3 2163 1784
To register your attendance for this webinar please click the link below.